taurocholic acid has been researched along with Hepatitis B, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuge, M | 1 |
| Chen, J; Chen, T; Guo, J; Huang, J; Lin, J; Liu, C; Ou, Q; Shang, H; Wu, S; Wu, W; Xu, S; Xun, Z; Ye, Y; Yu, Q; Zeng, Y | 1 |
1 review(s) available for taurocholic acid and Hepatitis B, Chronic
| Article | Year |
|---|---|
Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Disease Models, Animal; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Mice; Symporters; Taurocholic Acid; Virus Replication | 2021 |
1 other study(ies) available for taurocholic acid and Hepatitis B, Chronic
| Article | Year |
|---|---|
Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
Topics: Animals; Antiviral Agents; Case-Control Studies; CD8-Positive T-Lymphocytes; Cholagogues and Choleretics; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Killer Cells, Natural; Mice; Mice, Inbred C57BL; Taurocholic Acid | 2021 |